Acute and chronic methylphenidate modulates the neuronal activity of the caudate nucleus recorded from freely behaving rats

Brain Research Bulletin

Volumn 87, Issue 4-5, 2012, Pages 387-396

  Claussen, Catherine ^a   Dafny, Nachum ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Behavior sensitization tolerance; Caudate nucleus; Electrophysiology; Ritalin; Single unit activity

Indexed keywords

METHYLPHENIDATE;

ACUTE DRUG ADMINISTRATION; AMPLITUDE MODULATION; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG RECHALLENGE; MALE; MICROELECTRODE; NERVE CELL; NERVE CONDUCTION; NEUROMODULATION; NEUROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RAT; SENSITIZATION; TELEMETRY;

ANIMALS; BEHAVIOR, ANIMAL; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG TOLERANCE; MALE; METHYLPHENIDATE; MICROELECTRODES; NEURONS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84857917888     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.10.008     Document Type: Article

References (67)

1. Algahim M.F., Yang P.B., Wilcox V.T., Burau K.D., Swann A.C., Dafny N. Prolonged methylphenidate treatment alters the behavioral diurnal activity pattern of adult male Sprague-Dawley rats. Pharmacol. Biochem. Behav. 2009, 92:93-99.
2. Amalric M., Koob G.F. Depletion of dopamine in the caudate nucleus but not in nucleus accumbens impairs reaction-time performance in rats. J. Neurosci. 1987, 7:2129-2134.
3. Askenasy E.P., Taber K.H., Yang P.B., Dafny N. Methylphenidate (Ritalin): behavioral studies in the rat. Int. J. Neurosci. 2007, 117:757-794.
4. Bramham C.R., Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog. Neurobiol. 2005, 76:99-125.
5. Burrone J., Murthy V.N. Synaptic gain control and homeostasis. Curr. Opin. Neurobiol. 2003, 13:560-567.
6. Carelli R.M., Ijames S.G. Selective activation of accumbens neurons by cocaine-associated stimuli during a water/cocaine multiple schedule. Brain Res. 2001, 907:156-161.
7. Chao J., Nestler E.J. Molecular neurobiology of drug addiction. Annu. Rev. Med. 2004, 55:113-132.
8. C.M. Claussen, S.L. Chong, N. Dafny, Selective bilateral lesion to caudate nucleus modulates the acute and chronic methylpheniate effects, Pharmacol. Biochem. Behav., in press.
9. Dafny N. Electrophysiological properties of caudate neurons following substantia nigra, motor cortex, and amygdaloid nuclear complex stimulation of the rat. Appl. Neurophysiol. 1975, 38:259-272.
10. Dafny N. Multiunit recording from medial basal hypothalamus following acute and chronic morphine treatment. Brain Res. 1980, 190:584-592.
11. Dafny N. The hypothalamus exhibits electrophysiologic evidence for morphine tolerance and dependence. Exp. Neurol. 1982, 77:66-77.
12. Dafny N., Terkel J. Hypothalamic neuronal activity associated with onset of pseudopregnancy in the rat. Neuroendocrinology 1990, 51:459-467.
13. Dietz D.M., Dietz K.C., Nestler E.J., Russo S.J. Molecular mechanisms of psychostimulant-induced structural plasticity. Pharmacopsychiatry 2009, 42(Suppl. 1):S69-S78.
14. Everitt B.J., Wolf M.E. Psychomotor stimulant addiction: a neural systems perspective. J. Neurosci. 2002, 22:3312-3320.
15. Fan D., Rich D., Holtzman T., Ruther P., Dalley J.W., Lopez A., Rossi M.A., Barter J.W., Salas-Meza D., Herwik S., Holzhammer T., Morizio J., Yin H.H. A wireless multi-channel recording system for freely behaving mice and rats. PLoS One 2011, 6:e22033.
16. Gatley S.J., Volkow N.D., Gifford A.N., Fowler J.S., Dewey S.L., Ding Y.S., Logan J. Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans. Psychopharmacology (Berl.) 1999, 146:93-100.
17. Gaytan O., Ghelani D., Martin S., Swann A., Dafny N. Dose response characteristics of methylphenidate on different indices of rats' locomotor activity at the beginning of the dark cycle. Brain Res. 1996, 727:13-21.
18. Gaytan O., Yang P., Swann A., Dafny N. Diurnal differences in sensitization to methylphenidate. Brain Res. 2000, 864:24-39.
19. Ghitza U.E., Fabbricatore A.T., Prokopenko V.F., West M.O. Differences between accumbens core and shell neurons exhibiting phasic firing patterns related to drug-seeking behavior during a discriminative-stimulus task. J. Neurophysiol. 2004, 92:1608-1614.
20. Greely H., Sahakian B., Harris J., Kessler R.C., Gazzaniga M., Campbell P., Farah M.J. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 2008, 456:702-705.
21. Jaffe S.L. Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with ADHD. J. Am. Acad. Child Adolesc. Psychiatry 1991, 30:773-775.
22. Joy B., McMahon R.P., Shepard P.D. Effects of acute and chronic clozapine on d-amphetamine-induced disruption of auditory gating in the rat. Psychopharmacology (Berl.) 2004, 174:274-282.
23. Kalivas P.W. Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Drug Alcohol Depend 1995, 37:95-100.
24. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Brain Res. Rev. 1991, 16:223-244.
25. Kim Y., Shin M.S., Kim J.W., Yoo H.J., Cho S.C., Kim B.N. Neurocognitive effects of switching from methylphenidate-IR to OROS-methylphenidate in children with ADHD. Hum. Psychopharmacol. 2009, 24:95-102.
26. Kollins S.H. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient. J. Clin. Psychiatry 2003, 64(Suppl. 11):14-18.
27. Kuczenski R., Segal D.S. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J. Neurochem. 1997, 68:2032-2037.
28. Lee M.J., Yang P.B., Wilcox V.T., Burau K.D., Swann A.C., Dafny N. Does repetitive Ritalin injection produce long-term effects on SD female adolescent rats?. Neuropharmacology 2009, 57:201-207.
29. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2001, 2:119-128.
30. Nestler E.J. Molecular mechanisms of drug addiction. Neuropharmacology 2004, 47(Suppl. 1):24-32.
31. Nestler E.J. Review. Transcriptional mechanisms of addiction: role of DeltaFosB. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2008, 363:3245-3255.
32. Nestler E.J., Malenka R.C. The addicted brain. Sci. Am. 2004, 290:78-85.
33. G. Paxinos, C. Watson, The rat brain in stereotaxic coordinates, 2nd edition. Academic Press, Orlando, 1986.
34. Piazza P.V., Deminiere J.M., Le M.M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science 1989, 245:1511-1513.
35. Pierce R.C., Kalivas P.W. Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J. Neurosci. 1997, 17:3254-3261.
36. Podet A., Lee M.J., Swann A.C., Dafny N. Nucleus accumbens lesions modulate the effects of methylphenidate. Brain Res. Bull. 2010, 82:293-301.
37. Prieto-Gomez B., Benitez M.T., Vazquez-Alvarez A.M., Yang P.B., Reyes V.C., Dafny N. Dopaminergic ventral tegmental neurons modulated by methylphenidate. Life Sci. 2004, 74:1581-1592.
38. Prieto-Gomez B., Vazquez-Alvarez A.M., Martinez-Pena J.L., Reyes-Vazquez C., Yang P.B., Dafny N. Methylphenidate and amphetamine modulate differently the NMDA and AMPA glutamatergic transmission of dopaminergic neurons in the ventral tegmental area. Life Sci. 2005, 77:635-649.
39. Reyes-Vazquez C., Prieto-Gomez B., Dafny N. Alpha-interferon suppresses food intake and neuronal activity of the lateral hypothalamus. Neuropharmacology 1994, 33:1545-1552.
40. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 1986, 396:157-198.
41. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 1993, 18:247-291.
42. Robinson T.E., Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 2004, 47(Suppl 1):33-46.
43. Russo S.J., Dietz D.M., Dumitriu D., Morrison J.H., Malenka R.C., Nestler E.J. The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens. Trends Neurosci. 2010, 33:267-276.
44. Teo S.K., Stirling D.I., Hoberman A.M., Christian M.S., Thomas S.D., Khetani V.D. d-Methylphenidate and d,l-methylphenidate are not developmental toxicants in rats and rabbits. Birth Defects Res. B: Dev. Reprod. Toxicol. 2003, 68:162-171.
45. Volkow N.D., Ding Y.S., Fowler J.S., Wang G.J., Logan J., Gatley J.S., Dewey S., Ashby C., Liebermann J., Hitzemann R. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch. Gen. Psychiatry 1995, 52:456-463.
46. Volkow N.D., Wang G.J., Fowler J.S., Fischman M., Foltin R., Abumrad N.N., Gatley S.J., Logan J., Wong C., Gifford A., Ding Y.S., Hitzemann R., Pappas N. Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain. Life Sci. 1999, 65:L7-L12.
47. Wise R.A. Intracranial self-stimulation: mapping against the lateral boundaries of the dopaminergic cells of the substantia nigra. Brain Res. 1981, 213:190-194.
48. Wolf M.E. Addiction: making the connection between behavioral changes and neuronal plasticity in specific pathways. Mol. Interv. 2002, 2:146-157.
49. Wolf M.E., Sun X., Mangiavacchi S., Chao S.Z. Psychomotor stimulants and neuronal plasticity. Neuropharmacology 2004, 47(Suppl. 1):61-79.
50. Yang P.B., Amini B., Swann A.C., Dafny N. Strain differences in the behavioral responses of male rats to chronically administered methylphenidate. Brain Res. 2003, 971:139-152.
51. Yang P.B., Swann A.C., Dafny N. Chronic pretreatment with methylphenidate induces cross-sensitization with amphetamine. Life Sci. 2003, 73:2899-2911.
52. Yang P.B., Swann A.C., Dafny N. Acute and chronic methylphenidate dose-response assessment on three adolescent male rat strains. Brain Res. Bull. 2006, 71:301-310.
53. Yang P.B., Swann A.C., Dafny N. Chronic methylphenidate modulates locomotor activity and sensory evoked responses in the VTA and NAc of freely behaving rats. Neuropharmacology 2006, 51:546-556.
54. Yang P.B., Swann A.C., Dafny N. Dose-response characteristics of methylphenidate on locomotor behavior and on sensory evoked potentials recorded from the VTA, NAc, and PFC in freely behaving rats. Behav. Brain Funct. 2006, 2:3.
55. Yang P.B., Swann A.C., Dafny N. Sensory-evoked potentials recordings from the ventral tegmental area, nucleus accumbens, prefrontal cortex, and caudate nucleus and locomotor activity are modulated in dose-response characteristics by methylphenidate. Brain Res. 2006, 1073-1074:164-174.
56. Yang P.B., Swann A.C., Dafny N. Chronic administration of methylphenidate produces neurophysiological and behavioral sensitization. Brain Res. 2007, 1145:66-80.
57. Yang P.B., Swann A.C., Dafny N. Psychostimulants given in adolescence modulate their effects in adulthood using the open field and the wheel-running assays. Brain Res. Bull. 2010, 82:208-217.
58. Yang P.B., Atkins K.D., Dafny N. Behavioral sensitization and cross-sensitization between methylphenidate amphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) in female SD rats. Eur. J. Pharmacol. 2011, 661:72-85.
59. Yang P.B., Cuellar D.O., Swann A.C., Dafny N. Age and genetic strain differences in response to chronic methylphenidate administration. Behav. Brain Res. 2011, 218:206-217.
60. Zahniser N.R., Larson G.A., Gerhardt G.A. In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors. J. Pharmacol. Exp. Ther. 1999, 289:266-277.
61. Zhang L., Lou D., Jiao H., Zhang D., Wang X., Xia Y., Zhang J., Xu M. Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors. J. Neurosci. 2004, 24:3344-3354.
62. Pierce R.C., Duffy P., Kalivas P.W. Sensitization to cocaine and dopamine autoreceptor subsensitivity in the nucleus Accumbens 13. Synapse. 1995, 20:33-36.
63. Girault J.A., Greengard P. The neurobiology of dopamine signaling. Arch. Neurol. 2004, 61:641-644.
64. Ruskin D.N., Bergstrom D.A., Baek D., Freeman L.E., Walters J.R. Cocaine or selective block of dopamine transporters influences multisecond oscillations in firing rate in the globus pallidus. Neuropsychopharmacology 2001, 25:28-40.
65. Einhorn L.C., Johansen P.A., White F.J. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area. J. Neurosci. 1988, 8:100-112.
66. Shi W.X., Smith P.L., Pun C.L., Millet B., Bunney B.S. D1-D2 interaction in feedback control of midbrain dopamine neurons. J. Neurosci. 1997, 17:7988-7994.
67. Kolb B., Pellis S., Robinson T.E. Plasticity and functions of the orbital frontal cortex. Brain Cogn. 2004, 55:104-115.